Therapeutic targets for MG were obtained from GeneCards [14] (https://www.genecards.org/) and DisGeNET [15] (https://www.disgenet.org/) databases. Candidate targets were collected after the deletion of duplicates.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.